Vol. 9, Issue 7 (2020)
A review on corona virus (Covid-19)
K Sowmya Sravani, N Harichandana, M Suprathika, SK Inthiyaz, G Swapna and V Joy Blessanna
There is a substitution public health crises causing the earth with the emergence and spread of 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus generated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, Hubei province, China in December 2019. There are approx. 96,000 reported positive cases of coronavirus disease 2019 (COVID-2019) and 3300 reported deaths thus far (05/03/2020). The disease is speeded by inhalation or contact with infected droplets and thus the period of time ranges from 2 to 14 d. The features are usually fever, cough, pharyngitis, breathlessness, fatigue, malaise among others. The disease is mild in most people; in some (usually the elderly and other people with comorbidities), it's getting to reach pneumonia, acute respiratory distress syndrome (ARDS) and multi organ dysfunction. many folks are asymptomatic. The case death rate is predicted to range from 2 to 3. Diagnosis is by demonstration of the virus in respiratory secretions by some molecular tests. Common laboratory findings are normal/ low leukocyte counts with elevated C-reactive protein (CRP). The computerized tomographic chest scan is usually abnormal even in those with no symptoms or mild disease. Treatment is really supportive; role of antiviral agents is yet to be established. Prevention entails home isolation of suspected cases and other people with mild illnesses and strict infection control measures at hospitals that include contact and droplet precautions. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower fatality. the worldwide impact of this new epidemic is yet uncertain.
How to cite this article:
K Sowmya Sravani, N Harichandana, M Suprathika, SK Inthiyaz, G Swapna, V Joy Blessanna. A review on corona virus (Covid-19). Pharma Innovation 2020;9(7):197-199.